DIRS.INFO The most relevant business & tech news

☆ Tampons contain lead, arsenic and potentially toxic chemicals, studies say. Here’s what to know
▼ + stars: | 2024-07-11 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

CNN —The average menstruating person will spend about five years of their total reproductive lifespan using an estimated 11,000 tampons, sanitary pads, panty liners and other menstrual products, experts say. What if some of those menstrual aids contain heavy metals or potentially toxic chemicals linked to chronic diseases and reproductive and developmental problems? “I do not want people to panic, but to be aware that heavy metals have been found in these menstrual products,” Schilling said. “However, there is no reason for people to be afraid to use menstrual products at this time,” she added. The team ran tests for 16 heavy metals: arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium and zinc.

Persons: Kathrin Schilling, ” Schilling, Amanda Hils, ” Hils, Anna Pollack, ”, Pollack, “, tampons Schilling, nonorganic tampons, hasn’t, Nancy King Reame, Reame Organizations: CNN, US Environmental Protection Agency, Columbia University’s Mailman, of Public Health, US Food and Drug Administration, George Mason University, US Geological Survey . Chemicals, Environmental Health, Institute for Green Science, Carnegie Mellon University, American Chemistry Council, “, for Disease Control, Prevention, FDA, School of Nursing, Columbia University Medical Center Locations: New York City, “, Fairfax , Virginia, United States, United Kingdom, Greece, tampons, Pittsburgh

☆ Musk says next Neuralink brain implant expected soon, despite issues with the first patient
▼ + stars: | 2024-07-10 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +3 min

Elon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its system in a second human patient within "the next week or so." No BCI company has received approval from the U.S. Food and Drug Administration to commercialize their devices. In a livestream with Neuralink executives Wednesday, Musk said the company is hoping to implant its device in the "high single digits" of patients this year. However, in the weeks following the procedure, Neuralink said some threads from the implant retracted from Arbaugh's brain. Musk and the Neuralink executives said during Wednesday's livestream that only around 15% of the channels in Arbaugh's implant are functional.

Persons: Elon Musk, Musk, Neuralink, Noland Arbaugh, Wednesday's, DJ Seo, Matthew MacDougall Organizations: BCI, Neuroscience, U.S . Food, Drug Administration, Barrow Neurological, FDA, Wall Street, CNBC Locations: U.S, Barrow, Phoenix , Arizona, Neuralink

☆ A brain expert explains the cognitive test used to assess a president's mental fitness. It's not easy.
▼ + stars: | 2024-07-10 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +10 min

There are also concerns about 78-year-old Republican nominee Donald Trump's fitness for office — registered voters are split on whether he still has the cognitive skills for this job. "I have a cognitive test every single day," he added, alluding to the requirements of his job. Trump continues to boast that he "aced" the basic cognitive tests he took over four years ago, when he was president. These cognitive tests only rule out disease. Doctors themselves have resisted mandatory cognitive tests for older physicians — in part because it's ageist, but also because memory tests don't tell you whether someone is good at their job.

Persons: —, Biden, Donald Trump's, neuropsychologist Joel Kramer, might've, Trump, Kramer, Dusan Stankovic, he's, There's, Biden's, George Stephanopoulos, Sanjay Gupta, Stephanopoulos, it's Organizations: Service, Republican, Business, University of California, SAGE, The Ohio State University, telltale, FDA, White Locations: San Francisco, Montreal

☆ We're hiking our price targets on Meta, Eli Lilly, and 3 other stocks on recent runs higher
▼ + stars: | 2024-07-09 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

AMZN YTD mountain Amazon YTD We begin with Amazon 's move, which has been fueled by strength in its three core businesses. GOOGL YTD mountain Alphabet YTD Alphabet has been gaining steam in recent months on similar cloud tailwinds but also improving sentiment around its AI capabilities. META YTD mountain Meta Platforms YTD Meta Platforms ' stock has fully recovered all of its first-quarter earnings losses. LLY YTD mountain Eli Lilly YTD We are also increasing our Eli Lilly price target – taking it to $1,000 per share from $850. PANW YTD mountain Palo Alto Networks YTD One more stock we're raising our price target for is Palo Alto Networks .

Persons: Eli Lilly, Eli Lilly YTD, There's, donanemab, We're, Jim Cramer's, Jim Cramer, Jim, Beata Zawrzel Organizations: Palo Alto Networks, Amazon, Jefferies, Facebook, Alto Networks, CNBC, Google, Nurphoto, Getty Locations: CIOs, United States, Indiana, Palo

☆ Mounjaro leads to significantly more weight loss than Ozempic, study suggests
▼ + stars: | 2024-07-08 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +4 min

CNN —People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. But 82% of people taking tirzepatide reached this important clinical benchmark, compared with about 67% of those taking semaglutide. Average weight loss was also consistently higher among those taking tirzepatide over time. And by one year, average weight loss was nearly double for those taking tirzepatide — more than 11%, compared with about 6% for those taking semaglutide. According to the new study, individuals with type 2 diabetes had less significant weight loss than those without a diagnosis — but average weight loss was still greater among those taking tirzepatide.

Persons: tirzepatide, Eli Lilly, ”, Dr, Sanjay Gupta, CNN’s Brenda Goodman Organizations: CNN, US Food and Drug Administration, Novo Nordisk, semaglutide, FDA, CNN Health Locations: Truveta

☆ Eli Lilly shares have plenty room to run even after hitting a new high on Monday
▼ + stars: | 2024-07-08 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Shares of the iPhone maker hit a new high after the opening. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Morgan Stanley, Wells, Eli Lilly, Joe Biden, Lilly's donanemab, Jim Cramer's Organizations: CNBC, Microsoft, Apple, Palo Alto Networks, Facebook, Palo, Bulls, Bears Locations: Palo, Palo Alto

☆ A woman's breast cancer was missed on multiple mammograms. She had higher breast density, which can hide tumors.
▼ + stars: | 2024-07-05 | by ( Julia Pugachevsky | ) www.businessinsider.com time to read: +5 min

Read previewJoAnn Pushkin did everything she could to spot breast cancer early. "So on the same day I learned I had breast cancer, I learned I had dense breasts, and I learned it had been missed because I had dense breasts." Even large tumors are hard to spot in some mammogramsA side-by-side mammogram image of cancer in a "not dense" breast and a "dense" breast. Related storiesAdditionally, having dense breasts also increases your risk of developing breast cancer, though the CDC said scientists are still unsure why. AdvertisementHow to assess your own riskWomen who are at high risk for breast cancer (regardless of breast density) should have a yearly MRI in addition to a mammogram.

Persons: —, JoAnn Pushkin, Pushkin, Katie Couric, Rosa DeLauro, Brian Fitzpatrick Organizations: Service, Business, FDA Locations: mammograms, New York

☆ Ozempic & Wegovy may be linked to eye condition, vision loss: Study
▼ + stars: | 2024-07-05 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOzempic & Wegovy may be linked to eye condition, vision loss: StudyFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing people taking Ozempic and Wegovy may be at an increased risk of developing an eye condition that can cause irreversible vision loss.

Persons: Scott Gottlieb

☆ 10 things to watch in the stock market Wednesday after the S&P 500's record close
▼ + stars: | 2024-07-03 | by ( Jeff Marks | ) www.cnbc.com time to read: +5 min

Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Loops Capital raised its price target for off-price retailer TJX to $125 from $115. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating. Pepsico 's price target was lowered to $190 from $200 at Cowen, which cited some weakness in salty snacks. Lululemon 's price target was lowered to $470 from $505 at Baird, but kept its outperform rating.

Persons: Tuesday's, depletions, Jefferies, Eli Lilly, Lululemon, Baird, BTIG, Dell, Amphenol, Jim Cramer's, Jim Cramer, Jim, John Thys Organizations: Constellation Brands, Pepsico, Cowen, Nike, MGM Resorts, Bank of America's, Jim Cramer's Charitable, CNBC, AFP, Getty Locations: Zeebrugge, Belgium

☆ FDA approves a new Alzheimer's drug from Eli Lilly
▼ + stars: | 2024-07-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFDA approves a new Alzheimer's drug from Eli LillyEvan Seigerman, BMO Capital Markets senior research analyst, joins 'Squawk Box' to discuss the FDA's approval of Eli Lilly's Alzheimer's drug donanemab, how much revenue it could add to Elil LIlly's bottom line, and the details behind the newly approved drug.

Persons: Eli Lilly Evan Seigerman, Eli Lilly's Organizations: FDA, BMO Capital Markets

☆ 7 supplements a personal trainer and bodybuilding coach takes daily to grow muscle, boost energy, and stay in shape
▼ + stars: | 2024-07-03 | by ( Rachel Hosie | ) www.businessinsider.com time to read: +5 min

Read previewIndustry-leading physique coach and former bodybuilder Cliff Wilson shared with Business Insider the seven supplements he takes daily. Creatine monohydrateWilson said he takes five grams of creatine monohydrate daily to help him build muscle and support his cognition and mood. Vitamin D"Effective and cheap, vitamin D supplements help to maintain my energy and hormone levels," Wilson said. The FDA says that 400 milligrams of caffeine a day is a healthy amount, but personal tolerances vary a lot. AdvertisementPotential benefits of glutamine supplements include reducing muscle soreness after workouts, boosting the immune system, and supporting muscle recovery.

Persons: —, Cliff Wilson, Wilson, monohydrate Wilson, Rhiannon Lambert, he's Organizations: Service, Business, American Medical Association, Nutrition, Getty, FDA Locations: Chicago

☆ Wall Street firm gets it right with Best Buy call, plus Eli Lilly shares move up
▼ + stars: | 2024-07-03 | by ( Morgan Chittum | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Davidson analysts touted Best Buy stock on Wednesday, listing artificial-intelligence-enabled PCs as a positive catalyst for the electronics retailer. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, Jeff Marks, Davidson, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, New York Stock Exchange, Independence, Food and Drug Administration, Jefferies Locations: U.S, D.A

☆ Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
▼ + stars: | 2024-07-03 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +6 min

CNN —People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. The condition is relatively rare — up to 10 out of 100,000 people in the general population may experience it — but the doctors noted three cases in one week, and each of those patients was taking semaglutide medications. The risk was found to be greatest within the first year of receiving a prescription for semaglutide. Semaglutide prescriptions have soared in the US, which could raise the number of people at risk for a potential side effect. But the large number of people who are taking semaglutide should raise confidence that the absolute risk of developing NAION as a result is rare.

Persons: ”, Joseph Rizzo, ” Susan Mollan, Disha, Dr, Sanjay Gupta, Chanapa, Andrew Lee, ” Narang Organizations: CNN —, Mass, Novo Nordisk, CNN, Harvard Medical School, ”, University Hospitals Birmingham, Endeavor Health, CNN Health, US Food and Drug Administration, FDA, American Academy of Ophthalmology, Houston Methodist Hospital Locations: Chicago

☆ FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
▼ + stars: | 2024-07-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. The Food and Drug Administration on Tuesday approved Eli Lilly 's Alzheimer's drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The agency approved the treatment, which will be sold under the brand name Kisunla, for adults with early symptomatic Alzheimer's disease, according to the company. "Having multiple treatment options is the kind of advancement we've all been waiting for — all of us who have been touched, even blindsided, by this difficult and devastating disease." It's a long-awaited win for Eli Lilly after donanemab faced obstacles in its path to market.

Persons: Eli Lilly, Joanne Pike, donanemab Organizations: Company, The, Drug Administration, U.S, Alzheimer's Association, FDA Locations: Indianapolis , Indiana, U.S

☆ In new criteria for Alzheimer’s, some see much-needed progress while others fear profit may be driving ‘diagnostic creep’
▼ + stars: | 2024-07-01 | by ( Brenda Goodman | ) edition.cnn.com time to read: +12 min

CNN —With another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the nonprofit Alzheimer’s Association has published the final version of its new diagnostic criteria for the disease. Together with another protein, tau, which makes fibrous tangles that block the communication of nerve cells, they are considered a hallmark of Alzheimer’s disease. “There’s no evidence for it,” said Dr. George Perry, a neurobiologist and editor of the Journal of Alzheimer’s Disease. Two members of the panel were employees of the Alzheimer’s Association, which also takes funding from pharmaceutical companies. Widera says he hopes that in the next round of guidelines, the Alzheimer’s Association will consider the risks involved.

Persons: There’s, –, donanemab, “, ”, George Perry, Adriane Fugh, Berman, haven’t, Maria C, Carrillo, Alzheimer’s, It’s, Eric Widera, Widera, it’s, Aduhelm, Karl Herrup, Clifford Jack, ” Jack, “ It’s, Niles Franz, ” Franz, Dr, Sanjay Gupta, Franz, ” Widera Organizations: CNN, Alzheimer’s Association, Food and Drug Administration, FDA, Georgetown University, University of California San, American Geriatrics Society, Abbott Labs, University of Pittsburgh School of Medicine, Mayo Clinic, Nature Medicine, federal National Institute, Aging, Alzheimer’s Association International, National Institute, National Institutes of Health, NIA, Alzheimer’s, National Academy of Medicine, CNN Health, Association Locations: University of California San Francisco

☆ Former FDA Commissioner Dr. Scott Gottlieb on Supreme Court overturning the 1984 Chevron precedent
▼ + stars: | 2024-07-01 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on Supreme Court overturning the 1984 Chevron precedentFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to weigh in on the Supreme Court's decision to overturn the 1984 Chevron precedent and more.

Persons: Scott Gottlieb Organizations: Former, Chevron, FDA

☆ Australia restricts vape sales to pharmacies in ‘world-leading’ move to cut nicotine use
▼ + stars: | 2024-07-01 | by ( Hilary Whiteman | ) edition.cnn.com time to read: +4 min

Brisbane, Australia CNN —Buying a vape just got harder in Australia with the introduction of some of the world’s toughest anti-vaping laws that limit the sale of vapes with nicotine to pharmacies. From Monday, users will need to present a doctor’s prescription to a pharmacist to buy vapes, and the choice will be limited to three flavors: mint, menthol and tobacco. Dozens of countries have banned disposable vapes, but with the ban on vape sales in shops, service stations and other small retailers, Australia has introduced “world leading” laws, according to the government. Adults will be able to buy vapes in pharmacies, without a prescription – but the devices may be hard to find after some leading pharmacy chains declared they would refuse to stock them. Despite the rising cost of cigarettes, some fear that young vapers – having been locked out of the vape market – will turn to cigarettes to get their nicotine fix.

Persons: It’s, ”, Mark Butler, Anthony Tassone, Jordon Steele, John, vapers, ’ ” Hester Wilson Organizations: Australia CNN, Pharmacy Guild of Australia, Australia’s Greens Party, Greens, ” Greens, vapes, Royal Australian College of General, ABC, US Food and Drug Administration, FDA, Justice Department Locations: Brisbane, Australia, United States, United Kingdom

CNN —A major Supreme Court ruling Friday that shifted power from the executive branch to the judiciary stands to transform how the federal government works. By overturning a 1984 precedent, the court’s conservative majority has made countless regulations vulnerable to legal challenge. The Supreme Court ruling could boost efforts by conservatives who have taken aim at the Biden Environmental Protection Agency’s rules limiting planet-warming pollution from vehicles, oil and gas wells and pipelines, and power plants. The ruling has injected legal uncertainty into regulations of all types, including those on technology, labor, the environment and health care. But the Supreme Court has yet to decide a case heard this term that might gut that limitation.

Persons: ”, Kent Barnett, —, Thomas Berry, John Roberts, Roberts, Elena Kagan, Sonia Sotomayor, Joe Biden, Shawn ThewPool, Adam Rust, ” Rust, Andrew Schwartzman, Alexander MacDonald, ” MacDonald, Sharon Block, ” Block, Biden, Andrew Twinamatsiko, ” Twinamatsiko, “, Paul Gallant, TD Cowen, David Vladeck, Chevron —, Ann Carlson, Carlson, David Doniger Organizations: CNN, Biden, University of Georgia School of Law, Chevron, Natural Resources Defense, Republican, Democratic, Cato Institute . Chief, State of, Consumer, Consumer Financial Protection Bureau, Federal Trade Commission, Consumer Federation of America, “, Supreme, Securities, Exchange Commission, Benton Institute for Broadband & Society, Department of Labor, National Labor Relations Board, Opportunity Commission, Harvard Law School, Center, Labor, American Cancer Society, US Food and Drug Administration, US Department of Health, Human Services, Medicare, Services, Medicaid, Human Services Department, HHS, O’Neill Institute for National, Global Health Law, Georgetown University, FDA, Federal Communications Commission, EPA, National, Traffic Safety Administration, University of California, Natural Resources Defense Council Locations: Obamacare, Chevron, State, Washington , DC, Texas, Littler, Los Angeles

☆ A new study suggests a culprit in bird flu's rapid spread through US cattle, and how to stop it
▼ + stars: | 2024-06-29 | by ( Morgan Mcfall-Johnsen | ) www.businessinsider.com time to read: +5 min

Read previewContaminated milk may be spreading H5N1 bird flu between dairy cattle, contributing to a major outbreak across 12 US states. A new study shows the virus can survive for over an hour in raw (unpasteurized) milk left on the surfaces of materials used in equipment for milking dairy cattle. That's a clue in the mystery of how the virus has spread so rapidly between US dairy cattle, infecting over 130 herds in Idaho, Michigan, Colorado, Texas, and more. The cattle outbreak has scientists increasingly worried that the H5N1 virus could mutate enough to cause an outbreak in humans. However, the study suggests that cleaning milking equipment between cows and outfitting workers with protective gear could help prevent the spread.

Persons: —, Cynthia Goldsmith, Jackie Katz, Christopher Dye, Tony Kanaan, Jeff Haynes, Tom Vilsack, Meghan Davis, Davis, Robert F Organizations: Service, Business, CDC, AP, University of Oxford, FDA, Indianapolis, Indianapolis Motor, Reuters, Johns Hopkins Bloomberg School of Public Health, Workers Locations: Idaho , Michigan, Colorado , Texas, Brazil, Clinton , Maine, milkings

☆ A summer wave of Covid-19 has arrived in the US
▼ + stars: | 2024-06-28 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +6 min

CNN —Covid-19 levels have been rising in the United States for weeks as new variants drive what’s become an annual summer surge. That’s enough time to offer protection during the winter respiratory virus season but probably after this summer’s wave has ebbed. On Thursday, the CDC recommended that everyone ages 6 months and older receive an updated Covid-19 vaccine for the 2024-25 season. Unlike flu and RSV, Covid-19 is constantly circulating; it doesn’t offer a reprieve. The changes are meant to “simplify RSV vaccine decision-making for clinicians and the public,” the agency said.

Persons: CNN —, ”, Robert Hopkins, ” Hopkins, Marlene Wolfe, “, Dr, Jerry Weir, Marcus Plescia, Plescia, Sanjay Gupta, ” CNN’s Jen Christensen Organizations: CNN, US Centers for Disease Control, CDC, National Foundation for Infectious Diseases, Stanford University, Emory University, Emory, WastewaterSCAN, FDA, Viral Products, Vaccines Research, FDA’s, Biologics, Association of State, Territorial Health, CNN Health Locations: United States, —, Covid

☆ Compass Point's Max Reale talks the impact of a possible FDA ban on compounded GLP-1 offerings
▼ + stars: | 2024-06-27 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCompass Point's Max Reale talks the impact of a possible FDA ban on compounded GLP-1 offeringsMax Reale, Compass Point head of policy research, joins 'Closing Bell Overtime' to talk the current state of the weight-loss drug space and the impact of a possible compounded GLP-1 ban.

Persons: Max Reale Organizations: FDA

☆ How cleanliness can increase your restaurant's bottom line in 5 critical areas
▼ + stars: | 2024-06-27 | by ( Sponsor Post | Sponsored Ecolab | ) www.businessinsider.com time to read: +5 min

When it comes to reviewing a restaurant, cleanliness is one of the most critical concerns for guests. To maximize revenue, restaurant industry businesses should consider a holistic, company-wide approach to advancing a higher level of cleanliness. Employee turnover is reducedIt's no secret that employee churn is a challenge in the restaurant industry, with turnover rates reaching as high as 80%. However, after these seven businesses committed to the Ecolab Science Certified program, 72% of employees said this would "help them stay," further boosting the bottom line. For restaurant industry businesses, cleanliness is essential – it helps improve your online reviews, maintain a better relationship with the Health Department, increase foot traffic, and boost employee retention.

Persons: Ecolab Organizations: Ecolab, Health Department, ESC, Health Department Intelligence, CDC, FDA, Ecolab Science, Insider Studios Locations: Ecolab

☆ Snapchill canned coffee recalled in the US over botulism fears
▼ + stars: | 2024-06-26 | by ( Anna Cooban | ) edition.cnn.com time to read: +2 min

London CNN —All Snapchill canned coffee products are being recalled across the United States because of fears they may contain a deadly toxin. The botulinum toxin can cause botulism, a rare but potentially fatal disease, according to the World Health Organization (WHO). “Snapchill is working on filing the appropriate notification with FDA,” the statement added. Snapchill distributed its products across the country through coffee roasters and retail outlets, as well as its own website. “Consumers should either destroy the products or return the product to Snapchill or the place of purchase for a refund,” the statement on the FDA’s website said.

Persons: ” “ Organizations: London CNN, Food and Drug Administration, FDA, World Health Organization, WHO, “ Locations: United States

☆ Grail expected to be first FDA-approved multi-cancer test, says CEO Bob Ragusa
▼ + stars: | 2024-06-25 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGrail expected to be first FDA-approved multi-cancer test, says CEO Bob RagusaGrail CEO Bob Ragusa joins CNBC's 'Squawk Box' to discuss the company's debut on the Nasdaq, how Grail is innovating early cancer detection, and more.

Persons: Bob Ragusa Organizations: FDA, Nasdaq Locations: CNBC's

☆ Belgian AI startup TechWolf has raised $40 million to expand to the US. Here's the 19-slide pitch deck it used to raise the funds.
▼ + stars: | 2024-06-25 | by ( Callum Burroughs | ) www.businessinsider.com time to read: +2 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewTechWolf, a Belgian AI company that helps businesses understand their employees' skill sets, has raised $40 million in funding. Founded in 2018 by three university friends, TechWolf uses large language models to help large companies understand the skill sets of their workforce and to help re-train or re-deploy staff. The startup works with companies like United Airlines and Workday to help employers better manage and identify their staff's skills and skills gaps. This story is available exclusively to Business Insider subscribers.

Persons: —, Andreas de Neve, de Neve, Felix Organizations: Service, United Airlines, Business, Felix Capital, Acadian Ventures, Fortino Capital Partners, Notion, SemperVirens, SAP, ServiceNow Ventures Locations: Belgian, Ghent, Belgium, TechWolf

Search resuls for: "FDA"

25 mentions found